Budesonide

Green-G

Brand Name(s):

Indication:Treatment of Covid-19 (off-label) in adults over 50 years old.

Rationale:1,2,5

Considered:May-21

Review Date:May-26

Comments:
Based on interim results of PRINCIPLE trial which shows that inhaled budesonide can reduce recovery time for COVID-19 positive patients, it can now be prescribed off-label by healthcare professionals on a case-by-case basis using the information described in this Statement.